Lodestar UTI to be presented at two major urology congresses

Llusern Scientific is delighted to announce that Lodestar DX will be present at two leading urology conferences in 2026.

The urology team at the Royal Berkshire NHS Foundation Trust will present their paper, “Evaluating the rapid uropathogen identifier Lodestar DX against standard culture and dipstick for pre-operative screening”, at the European Association of Urology meeting in London (13-16 March 2026).

Two months later the team will present the same abstract at the American Urological Association meeting in Washington (15-18 May) along with a second paper titled “Optimizing outpatient urology care with the Lodestar DX rapid urine analyser: Real-time uropathogen identification and antibiotic stewardship.”

Congratulations to Dr Saif Kazi, Clemence Musabyimana P.A. and Mr Bob Yang, Urology Consultant who ran the studies, analysed the data and wrote the abstracts.